Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NNOX
NNOX logo

NNOX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.870
Open
1.790
VWAP
1.78
Vol
3.49M
Mkt Cap
120.74M
Low
1.730
Amount
6.21M
EV/EBITDA(TTM)
--
Total Shares
69.59M
EV
62.87M
EV/OCF(TTM)
--
P/S(TTM)
8.54
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
Show More

Events Timeline

(ET)
2026-04-23
09:10:00
Nano-X Imaging Signs Distribution Agreement with Radiology Oncology Systems
select
2026-04-20 (ET)
2026-04-20
16:30:00
Major Averages Decline Amid Escalating Tensions with Iran
select
2026-04-20
12:00:00
Major Averages Decline Amid Rising Tensions with Iran
select
2026-04-20
09:00:00
U.S. Stock Futures Decline Amid Rising Tensions with Iran
select
2026-04-20
08:50:00
Company Restructures to Align Manufacturing Costs with Financial Model
select
2026-04-20
08:40:00
CFO Ran Daniel Announces Resignation
select
2026-04-20
08:40:00
Nano-X Imaging Expects Revenue Growth to Depend on System Activation Timing
select
2026-04-20
08:40:00
Q1 Revenue at $3.72M, Below Consensus of $3.99M
select

News

Globenewswire
7.0
04-23Globenewswire
Nano-X Faces Investor Lawsuit Investigation
  • Financial Loss Disclosure: On April 20, 2026, Nano-X reported a net loss of $33.4 million for Q4 2025, which included a $17.5 million impairment charge due to restructuring at its Korean chip manufacturing facility, raising significant investor concerns about the company's financial health.
  • Executive Departure Impact: The announcement that CFO Ran Daniel will resign on July 31, 2026, may exacerbate market worries regarding the company's future financial stability, leading to a further decline in investor confidence.
  • Stock Price Volatility: Following the earnings report, Nano-X's stock price plummeted from $2.85 per share on April 17, 2026, to $2.15 per share on April 20, reflecting a 25% drop and indicating strong market reactions to the company's financial disclosures.
  • Legal Investigation Initiated: Bragar Eagel & Squire, P.C. is investigating whether Nano-X has violated federal securities laws, encouraging affected investors to reach out for legal options, highlighting the potential legal risks and liabilities facing the company.
seekingalpha
9.5
04-20seekingalpha
Nano-X Imaging Shares Plunge 17% Amid CFO Change and Q4 Miss
  • Earnings Miss: Nano-X Imaging reported Q4 2025 revenue of $3.7 million, missing consensus by $0.3 million, leading to a ~17% drop in shares on Monday, potentially marking its worst intraday decline in over two years.
  • Surging Net Loss: The company's net loss for Q4 surged approximately 137% year-over-year to $33.4 million, primarily due to a $17.5 million impairment charge from restructuring efforts, indicating a significant deterioration in financial health.
  • CFO Transition: Nano-X announced Guy Nathanzon from Valens Semiconductor as the new CFO, replacing Ran Daniel, who will step down on July 31, 2026, after five years, which may impact future financial strategies.
  • Outlook Reaffirmed: Despite recording $13 million in revenue for 2025, Nano-X reiterated its full-year revenue outlook of $35 million for 2026, reflecting confidence in future growth, although the timing of system activations will influence revenue growth pace.
seekingalpha
9.5
04-20seekingalpha
Nano-X Imaging Reports Q4 Earnings Miss
  • Earnings Miss: Nano-X Imaging reported a Q4 GAAP EPS of -$0.50, missing expectations by $0.28, indicating challenges in profitability that could undermine investor confidence.
  • Revenue Growth Pressure: Although revenue increased by 24.0% year-over-year to $3.72M, it fell short of expectations by $0.27M, suggesting competitive pressures that may hinder future growth potential.
  • Stock Price Reaction: Following the earnings report, Nano-X Imaging's shares dropped by 5%, reflecting a negative market reaction to the results, which may prompt investors to reassess their strategies.
  • Distribution Deal Impact: Despite securing a distribution agreement with Elite Surgical that enhances market prospects, the earnings miss may overshadow this positive development, affecting the company's image among investors.
seekingalpha
9.5
04-17seekingalpha
Nano-X Imaging Scheduled to Announce Q4 Earnings on April 20
  • Earnings Announcement: Nano-X Imaging is set to release its Q4 earnings on April 20 before the market opens, with a consensus EPS estimate of -$0.15, reflecting a 34.8% year-over-year improvement, indicating potential for enhanced profitability.
  • Revenue Expectations: Analysts project revenue to reach $3.99 million, representing a 33.0% year-over-year increase, suggesting significant growth in market demand and improved acceptance of its products.
  • Historical Performance Review: Over the past two years, Nano-X has only beaten EPS estimates 25% of the time and has not exceeded revenue estimates, indicating challenges in achieving revenue growth and necessitating close monitoring of future performance.
  • Market Reaction: Following a distribution deal with Elite Surgical, Nano-X's stock price has risen, and the company has received FDA approval for its image enhancement capabilities, showcasing positive advancements in technology innovation and market expansion.
Newsfilter
8.5
04-16Newsfilter
Nanox.ARC X Wins Red Dot Award for Design Excellence
  • Award Recognition: Nanox Imaging's Nanox.ARC X has been awarded the prestigious Red Dot Award for Product Design 2026, highlighting its innovative capabilities in the medical imaging sector and is expected to enhance brand visibility and attract more customer interest.
  • Technological Innovation: The system integrates advanced digital tomosynthesis technology with a significantly reduced physical footprint, allowing for quick installation and seamless integration into clinical environments, thereby improving operational efficiency for healthcare facilities and enhancing patient experiences.
  • Global Showcase Opportunities: The Nanox.ARC X will be featured in the Red Dot Design Yearbook and various international exhibitions, which not only boosts its global visibility but may also facilitate future market expansion and sales growth.
  • Strengthened Strategic Vision: CEO Erez Meltzer emphasized that good design is fundamental to the broader adoption of advanced imaging technologies, and this award further reinforces Nanox's strategic goals of advancing preventive healthcare and improving patient outcomes.
Yahoo Finance
4.5
04-01Yahoo Finance
Healthcare Stocks Rise, Market Reacts Positively
  • Healthcare Stocks Surge: Late Wednesday afternoon, healthcare stocks rose significantly, driven by the NYSE Health Care Index, indicating a rebound in market confidence towards the sector, possibly reflecting investor optimism regarding future healthcare policies.
  • Positive Market Reaction: The rise in healthcare stocks has improved investor sentiment, which may attract more capital into the sector, further driving up stock prices of related companies and enhancing market vitality.
  • Optimistic Industry Outlook: The growth potential of the healthcare industry has captured investor attention, particularly in areas of new drug development and medical technology innovation, which are expected to yield substantial revenue growth for related firms.
  • Increased Investor Confidence: The uptick in healthcare stocks not only reflects the current positive market sentiment but may also signal signs of future economic recovery, further bolstering investor confidence in long-term investments within the healthcare sector.
Wall Street analysts forecast NNOX stock price to rise
2 Analyst Rating
Wall Street analysts forecast NNOX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
7.00
Averages
7.00
High
7.00
Current: 0.000
sliders
Low
7.00
Averages
7.00
High
7.00
Alliance Global
Buy
to
Buy
downgrade
$7 -> $5
AI Analysis
2026-04-22
New
Reason
Alliance Global
Price Target
$7 -> $5
AI Analysis
2026-04-22
New
downgrade
Buy
to
Buy
Reason
Alliance Global lowered the firm's price target on Nano-X Imaging to $5 from $7 and keeps a Buy rating on the shares. The company reported Q4 results that were within the firm's expectations, with the main points of the print including that the quarter was in-line with AGP forecasts, management maintained 2026 revenue guidance, implying a significant upward breakout from current trends, and the company highlighting recent distribution agreements, the analyst tells investors in a research note. The firm added that it remains more conservative pending data points of execution.
Alliance Global Partners
Buy
downgrade
$9 -> $7
2025-05-22
Reason
Alliance Global Partners
Price Target
$9 -> $7
2025-05-22
downgrade
Buy
Reason
Alliance Global Partners lowered the firm's price target on Nano-X Imaging to $7 from $9 and keeps a Buy rating on the shares. The firm cites the company's Q1 revenue missing forecasts, suggesting a challenging macro environment, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NNOX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Nano-X Imaging Ltd (NNOX.O) is 0.00, compared to its 5-year average forward P/E of -10.16. For a more detailed relative valuation and DCF analysis to assess Nano-X Imaging Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-10.16
Current PE
0.00
Overvalued PE
-4.45
Undervalued PE
-15.86

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.42
Current EV/EBITDA
-0.28
Overvalued EV/EBITDA
6.94
Undervalued EV/EBITDA
-9.79

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
291.67
Current PS
2.09
Overvalued PS
1247.58
Undervalued PS
-664.24

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

create swing trade setup
Intellectia · 358 candidates
Price: $1.00 - $5.00List Exchange: XNAS, XNYS, XASEMoving Average Relationship: PriceAboveMA20, PriceBelowMA5, PriceBelowMA10Week Price Change Pct: $-10.00 - $10.00Macd: bullish, positive
Ticker
Name
Market Cap$
top bottom
TCRT logo
TCRT
Alaunos Therapeutics Inc
7.60M
OSTX logo
OSTX
OS Therapies Inc
53.17M
NNOX logo
NNOX
Nano-X Imaging Ltd
169.34M
FLNT logo
FLNT
Fluent Inc
107.58M
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
685.30M
MRT logo
MRT
Marti Technologies Inc
175.91M
Give me something more volatile
Intellectia · 18 candidates
Market Cap: 30.00M - 1000.00MPrice: $0.50 - $25.00Price Change Pct: >= $5.00Beta: HighRiskWeek Price Change Pct: >= $3.00
Ticker
Name
Market Cap$
top bottom
PSFE logo
PSFE
Paysafe Ltd
428.67M
KZIA logo
KZIA
Kazia Therapeutics Ltd
113.47M
ACVA logo
ACVA
ACV Auctions Inc
964.36M
SABR logo
SABR
Sabre Corp
711.30M
LAW logo
LAW
CS Disco Inc
248.88M
AENT logo
AENT
Alliance Entertainment Holding Corp
316.45M
what stock under $5 should I buy today?
Intellectia · 56 candidates
Market Cap: >= 100.00MRegion: USPrice: $0.50 - $5.00Quarter Revenue Yoy Growth: >= 5.0%List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
API logo
API
Agora Inc
431.16M
IOVA logo
IOVA
Iovance Biotherapeutics Inc
1.58B
GOGO logo
GOGO
Gogo Inc
599.67M
IMPP logo
IMPP
Imperial Petroleum Inc
188.03M
OCGN logo
OCGN
Ocugen Inc
608.82M
TRON logo
TRON
TRON Inc
359.44M
list top top 20 ai companies
Intellectia · 18 candidates
Themes: AI Beneficiary
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
MSFT logo
MSFT
Microsoft Corp
3.30T
META logo
META
Meta Platforms Inc
1.54T
MU logo
MU
Micron Technology Inc
437.95B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
PLTR logo
PLTR
Palantir Technologies Inc
394.05B
good penny stocks to invest in
Intellectia · 32 candidates
Market Cap: <= 500.00MPrice: <= $5.00Quarter Revenue Yoy Growth: >= 10.0%Beta: HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAN logo
CAN
Canaan Inc
498.64M
ORGO logo
ORGO
Organogenesis Holdings Inc
487.34M
CERS logo
CERS
Cerus Corp
485.98M
OCGN logo
OCGN
Ocugen Inc
465.36M
API logo
API
Agora Inc
402.42M
NNDM logo
NNDM
Nano Dimension Ltd
395.43M
ai companies
Intellectia · 18 candidates
Themes: AI BeneficiaryWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
MSFT logo
MSFT
Microsoft Corp
3.30T
META logo
META
Meta Platforms Inc
1.54T
MU logo
MU
Micron Technology Inc
437.95B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
PLTR logo
PLTR
Palantir Technologies Inc
394.05B
what AI company's have equity divedends
Intellectia · 14 candidates
Dividend Yield Ttm: >= 0Themes: AI BeneficiaryIs Optionable: True
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
MSFT logo
MSFT
Microsoft Corp
3.30T
META logo
META
Meta Platforms Inc
1.54T
MU logo
MU
Micron Technology Inc
437.95B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
PLTR logo
PLTR
Palantir Technologies Inc
394.05B

Whales Holding NNOX

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Nano-X Imaging Ltd (NNOX) stock price today?

The current price of NNOX is 1.735 USD — it has increased 1.17

What is Nano-X Imaging Ltd (NNOX)'s business?

Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.

What is the price predicton of NNOX Stock?

Wall Street analysts forecast NNOX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NNOX is7.00 USD with a low forecast of 7.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Nano-X Imaging Ltd (NNOX)'s revenue for the last quarter?

Nano-X Imaging Ltd revenue for the last quarter amounts to 3.72M USD, increased 23.97

What is Nano-X Imaging Ltd (NNOX)'s earnings per share (EPS) for the last quarter?

Nano-X Imaging Ltd. EPS for the last quarter amounts to -0.50 USD, increased 117.39

How many employees does Nano-X Imaging Ltd (NNOX). have?

Nano-X Imaging Ltd (NNOX) has 165 emplpoyees as of April 25 2026.

What is Nano-X Imaging Ltd (NNOX) market cap?

Today NNOX has the market capitalization of 120.74M USD.